Bone health, hormones and the real risk of osteoporosis

Summary of Key Wellness + Prevention Strategies (Bone Health, Hormones, Osteoporosis)

The discussion frames osteoporosis as a bone metabolism imbalance and emphasizes prevention through hormonal optimization, targeted diagnostics, and supporting healthy bone remodeling (building vs. breaking).

Key Wellness Strategies & Self-Care / Prevention Tips

• Reframe osteoporosis

  • Osteoporosis isn’t only a low T-score—it’s an imbalance in bone metabolism over time: too much breakdown versus too little build-up.

  • Practical implication: improve the imbalance by supporting bone formation and reducing excessive bone breakdown.

• Exercise as a bone-loading stimulus

  • Bones respond dynamically to mechanical load (bending/flexing with walking and daily movement).
  • Consistent loading helps keep bones responsive and supports healthier remodeling.

• Correct vitamin D (and support the full mineral “toolkit”)

  • Vitamin D is strongly associated with bone health and acts like a hormone necessary for mineral utilization.
  • Calcium deficiency is described as less common in adults in the “western world,” while vitamin D deficiency can be common.
  • Vitamin D supports nutrient systems involved in bone metabolism, including:
    • Calcium
    • Magnesium
    • Vitamin K
    • Boron
  • Vitamin D is described as a “gateway” nutrient to this broader mineral toolkit.

• Inflammation-aware, holistic thinking

  • Low vitamin D may be more than a marker of poor health—potentially contributing to inflammatory processes relevant to chronic disease and bone outcomes.
  • Takeaway: consider bone health in the context of systemic health and inflammation, not in isolation.

• Hormone optimization—especially around menopause

  • Estrogen (estradiol) is presented as a powerful bone-protective option because it can act on both sides of bone metabolism:
    • slowing breakdown
    • supporting build-up
  • The conversation notes that HRT is FDA-licensed/used as a preventative for osteoporosis in some regions (as stated in the discussion).
  • The fear originating from the Women’s Health Initiative (WHI) is discussed, with emphasis that WHI results also included hip fracture risk reduction.

• Use of progesterone (particularly micronized progesterone)

  • Progesterone is described as potentially beneficial for musculoskeletal tissues, brain, nerves, and arteries.
  • Even after hysterectomy, progesterone may still matter because it’s relevant to bones and broader health, not only uterine protection.
  • Note from the discussion: progesterone is often studied alongside estrogen, so independent effects “how much it helps for bone alone” are less clear.

• Testosterone for bone strength (and broader vitality)

  • Testosterone is discussed as relevant to muscle mass, energy, and vitality, and possibly bone mineral density and hip fracture risk reduction (based on studies referenced).
  • A key barrier noted is regulatory/prescribing restriction for women—often limited to specific diagnosis codes—potentially preventing appropriate off-label evaluation when clinically relevant.
  • The argument: testosterone should be evaluated as a legitimate tool when used appropriately.

• Don’t treat hormones vs. bone drugs as mutually exclusive

  • The discussion argues some clinicians avoid combining HRT and bisphosphonates.
  • Counterpoint: if HRT improves bone turnover dynamics, it may influence how effectively antiresorptive therapy works.
  • Bottom line: individualized planning and patient choice matter; combination therapy may be possible when indicated.

Practical “Method” for Preventing / Monitoring Osteoporosis (3 Take-Home Tips)

1. Before hormone optimization: get baseline bone information

   • If you’re perimenopausal/postmenopausal and considering hormone optimization, measure bone density/quality first to avoid missing major pieces of the puzzle.

2. Use more than one bone assessment, and track it over time

   • Consider imaging/data sources such as:
     • DEXA (density)
     • REMS ultrasound (measures density and quality; described as more available in the UK)
   • If bones are declining, “something’s wrong”—the cause may involve hormones, diet, or other factors.

3. Use bone turnover markers to guide decisions between scans

   • Between imaging intervals, consider bone turnover markers to assess whether bone metabolism is improving:
     • P1NP
     • CTX
   • Suggested monitoring rhythm (as stated):
     • REMS: about every 6 months
     • DEXA: about every 12 months

Presenters / Sources

• Dr. Doug Lucas (US orthopedic surgeon; bone and hormone specialist)
• Professor Albright (1941) (historical source discussed regarding estrogen and osteoporosis)
• Endocrine Society (US) guidelines (referenced regarding vitamin D testing cost/benefit)
• Women’s Health Initiative (WHI) study (referenced; including hip fracture reduction with conjugated equine estrogen/Premarin)
• P1NP and CTX (bone turnover markers)
• DEXA and REMS (bone imaging/measurement tools)